Open Access

TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis

  • Authors:
    • Zhicheng Huang
    • Shuangyan Sun
    • Changliang Yang
    • Jun Zheng
    • Yingji Nan
    • Ruikun Zhao
    • Zhiguo Lang
    • Hang Li
    • Lixia Ma
  • View Affiliations

  • Published online on: August 24, 2017     https://doi.org/10.3892/etm.2017.5024
  • Pages: 4254-4262
  • Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The differentiation of fibroblasts to myofibroblasts is critical for the development of idiopathic pulmonary fibrosis (IPF). T‑cell lymphoma invasion and metastasis 1 (TIAM1) is known to be associated with amyotrophic lateral sclerosis 1 and colorectal cancer; however, its role in IPF is unclear. The aim of the present study was to investigate the expression and roles of TIAM1 in lung fibroblasts during pulmonary fibrosis. It was demonstrated that TIAM1 expression was significantly increased in fibrotic lung tissue and lung fibroblasts from bleomycin (BLM)‑treated mice compared with control mice (P<0.05). TIAM1 expression and differentiation were significantly upregulated in human lung fibroblasts challenged with transforming growth factor‑β (TGF‑β) compared with unchallenged cells (P<0.05). Furthermore, inhibition of the nuclear factor (NF)‑κB signaling pathway significantly attenuated TGF‑β‑induced TIAM1 expression and decreased fibroblast differentiation in human lung fibroblasts (P<0.05). Similarly, overexpression of TIAM1 significantly inhibited TGF‑β‑induced fibroblast differentiation, as indicated by decreased expression of fibronectin and α‑smooth muscle actin (SMA; P<0.05). The results of the present study also demonstrated that TIAM1 knockdown increased TGF‑β‑induced fibroblast differentiation (P<0.05). These findings suggest that TIAM1 expression is associated with lung fibroblast differentiation in pulmonary fibrosis via an NF‑κB‑dependent pathway, and that TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 14 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huang Z, Sun S, Yang C, Zheng J, Nan Y, Zhao R, Lang Z, Li H and Ma L: TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis. Exp Ther Med 14: 4254-4262, 2017.
APA
Huang, Z., Sun, S., Yang, C., Zheng, J., Nan, Y., Zhao, R. ... Ma, L. (2017). TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis. Experimental and Therapeutic Medicine, 14, 4254-4262. https://doi.org/10.3892/etm.2017.5024
MLA
Huang, Z., Sun, S., Yang, C., Zheng, J., Nan, Y., Zhao, R., Lang, Z., Li, H., Ma, L."TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis". Experimental and Therapeutic Medicine 14.5 (2017): 4254-4262.
Chicago
Huang, Z., Sun, S., Yang, C., Zheng, J., Nan, Y., Zhao, R., Lang, Z., Li, H., Ma, L."TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4254-4262. https://doi.org/10.3892/etm.2017.5024